Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism

M D McColl1, N Sattar, J Ellison

  • 1Department of Haematology, Royal Infirmary, Glasgow, UK. mmccoll1@aol.com

Insights

Lipoprotein (a) is not significantly linked to venous thromboembolism (VTE) in young women. However, obesity may increase VTE risk through higher triglyceride levels, impacting clotting factors.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Metabolic Disorders

Background:

  • Venous thromboembolism (VTE) is a significant health concern, particularly in younger women.
  • Obesity is a known risk factor for VTE, but the underlying mechanisms require further elucidation.
  • Lipid profiles, including lipoprotein (a), are being investigated for their role in VTE pathogenesis.

Purpose of the Study:

  • To investigate the association between plasma lipoprotein (a) levels and objectively confirmed venous thromboembolism (VTE) in women aged 50 years or younger.
  • To examine differences in lipid profiles (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) between VTE cases and controls.
  • To assess the influence of body mass index (BMI) on these associations.

Main Methods:

  • A case-control study involving 62 women with VTE and 98 age-matched female controls.
  • Measurement of plasma concentrations of lipoprotein (a), total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglyceride.
  • Statistical analysis to compare lipid profiles and assess the impact of BMI.

Main Results:

  • Cases had significantly higher mean BMI and plasma triglyceride levels compared to controls.
  • Cases exhibited significantly lower total cholesterol and HDL-cholesterol levels.
  • After adjusting for BMI, total cholesterol and LDL-cholesterol remained significantly lower in cases.
  • No significant difference in mean plasma lipoprotein (a) levels was observed between VTE cases and controls.

Conclusions:

  • Plasma lipoprotein (a) does not appear to be significantly associated with the development of VTE in young women.
  • The increased VTE risk in obese individuals may be partly mediated by hypertriglyceridaemia.
  • Hypertriglyceridaemia's potential effects on coagulation factors and inhibitors warrant further investigation in the context of VTE risk.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...